CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Inventory Valuation and Obsolescence	[1]	Common Stock (at par value)	Additional Paid-In Capital	Accumulated Equity	Accumulated Equity Inventory Valuation and Obsolescence	[1]	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jan. 28, 2023	$ 4,040			$ 3	$ 467	$ 6,226			$ (2,038)	$ (618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	45					45
Other comprehensive income	122									122
Common stock dividends	(181)				2	(183)
Stock repurchases	(38)								(38)
Stock-based compensation expense	47				47
Stock issued under stock plans	0				(164)				164
Ending balance at Feb. 03, 2024	$ 4,035			3	352	6,088			(1,912)	(496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock dividends (in USD per share)	$ 0.66
Net income	$ 582					582
Other comprehensive income	47									47
Common stock dividends	(192)				2	(194)
Stock repurchases	(1)								(1)
Stock-based compensation expense	58				58
Stock issued under stock plans	0				(112)				112
Ending balance at Feb. 01, 2025	$ 4,552			3	300	6,499			(1,801)	(449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock dividends (in USD per share)	$ 0.69
Stockholders' Equity Attributable to Parent	$ 4,552	$ 23					$ 23
Net income	642					642
Other comprehensive income	57									57
Common stock dividends	(197)				3	(200)
Stock repurchases	(253)								(253)
Stock-based compensation expense	59				59
Stock issued under stock plans	0				(93)				93
Ending balance at Jan. 31, 2026	$ 4,860			$ 3	$ 269	$ 6,941			$ (1,961)	$ (392)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock dividends (in USD per share)	$ 0.73
Stockholders' Equity Attributable to Parent	$ 4,860

[1] Represents the cumulative-effect adjustment for the change in inventory valuation method.